Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Depression 3Neoplasms 2Hot Flashes 2Breast Neoplasms 2Pain 1Mental Disorders 1Lymphoma, Follicular 1Depressive Disorder, Major 1Caregiver Burden 1Anxiety Disorders 1

Interventions

Therapeutics 9Psychiatric Rehabilitation 9Music Therapy 8Cognitive Behavioral Therapy 7Mindfulness 6Surveys and Questionnaires 5Counseling 5Acupuncture Therapy 5Standard of Care 4Mindfulness-Based Stress Reduction 4Methods 4Imagery, Psychotherapy 4Early Intervention, Educational 4Autogenic Training 4Art Therapy 4Therapeutic Touch 3Psychosocial Intervention 3Psilocybin 3Mindfulness-Based Cognitive Therapy 3Massage 3Hypnosis 3Exercise 3Control Groups 3Aromatherapy 3Acceptance and Commitment Therapy 3Yoga 2Touch 2Observation 2Niacin 2Gabapentin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anxiety Disorders × Citalopram × Clear all
NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Kalaco Scientific, Inc.

Phase 2 Completed
120 enrolled
Lymphoid

Anxiety Disorders, Depression, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡